Researchers ID Potential Serum Biomarkers for Efficacy of Interferon-beta in Multiple Sclerosis

The research combined discovery-driven and targeted approaches and adds to a growing list of proteomics work directed at companion diagnostics.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.